RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Antibiotics, Antineoplastic

Back to Details
This is a "connection" page, showing publications Luis M. Vilá has written about Antibiotics, Antineoplastic.
Luis M. Vilá
Connection Strength
0.015
Antibiotics, Antineoplastic
  1. Calvo-Al?n J, McGwin G, Toloza S, Fern?ndez M, Roseman JM, Bastian HM, Cepeda EJ, Gonz?lez EB, Baethge BA, Fessler BJ, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis. 2006 Jun; 65(6):785-90.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support